DCGI grants Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group

Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation to COVID-19 vaccine Corbevax for children between 12-18 years of age group.

The vaccine has been developed by Hyderabad-based pharmaceutical company Biological E Ltd which country’s first indigenously developed Receptor Binding Domain protein sub-unit COVID-19 vaccine.

Earlier, the vaccine had received emergency use authorization for the adult population in December last year.

The Corbevax vaccine is administered through an intramuscular route with two doses scheduled 28 days apart and is stored at 2 to 8 degree Celsius temperature.